To understand the correlation between YAP and TAZ expression and the different subtypes of liver cancer, we evaluated their expression in K19-negative HCCs, K19-positive HCCs, cHCC-CCA, and CCA (Table 1). This evidence concerns the gene KRT19 and cholangiocarcinoma.